Results 201 to 210 of about 97,845 (268)

Tumor‐Specific Delivery of CD28 siRNA via Lyso‐PC C‐16 Modified Lipid Nanoparticles Overcomes Anti‐PD‐1 Resistance by Remodeling Tumor Microenvironment

open access: yesAdvanced Science, EarlyView.
This study develops 16:0 LPC‐modified lipid nanoparticles (LPC‐LNPs) with cancer cell specificity by exploiting altered tumor lipid metabolism. LPC‐LNPs encapsulating Cd28 small interfering RNA (LPC‐LNP‐Cd28) knock down cancer cell CD28 without affecting T cells, inflame the tumor microenvironment, and overcome anti‐PD‐1 resistance.
Yangyang Chai   +12 more
wiley   +1 more source

Autonomous microfluidic experimentation for exploring reaction inference and synthesizing double perovskite nanoplatelets. [PDF]

open access: yesNat Commun
Li J   +8 more
europepmc   +1 more source

Enhancing the Hemocompatibility of 3D-Printable Silicone Elastomers for Artificial Lung Applications. [PDF]

open access: yesLangmuir
Aggarwal R   +7 more
europepmc   +1 more source

A Novel Microfluidic System for Immunomagnetic Isolation of Pancreatic Cancer CTCs: Plectin‑1 and EpCAM as Potential Tumor Markers. [PDF]

open access: yesACS Omega
Baranowska P   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy